XML 46 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Total Operating Expenses $ 3,274,937 $ 2,430,008 $ 9,354,657 $ 7,417,391
Compensation expense related to the company's stock-based compensation plans $ 49,000 43,500 $ 116,300 101,500
Common Shares Available for Grant 13,700,000   13,700,000  
Stock Options and SARs [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Stock-based compensation expense related to stock options, SAR and ESPP grants $ 21,700 $ 20,900 $ 45,400 $ 42,900
Unrecognized compensation expense [1] $ 119,700   $ 119,700  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 3 months 18 days  
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 33.49 $ 23.94
Expected Volatility (in hundredths)     28.22% 28.28%
Risk-Free Interest Rate (in hundredths)     2.68% 1.52%
Dividend Yield (in hundredths)     0.72% 0.75%
Expected Life (in years)     5 years 5 years 1 month 6 days
Stock Options and SARs Rollforward [Abstract]        
Outstanding at January 1 (in shares)     9,103,000 9,850,000
Granted (in shares)     1,884,000 2,260,000
Exercised (1) (in shares) [1]     (2,144,000) (1,674,000)
Forfeited (in shares)     (167,000) (269,000)
Outstanding at September 30 (2) (in shares) [2] 8,676,000 10,167,000 8,676,000 10,167,000
Stock Options and SARs Vested or Expected to Vest (in shares) [3] 8,316,000 9,799,000 8,316,000 9,799,000
Stock Options and SARs Exercisable at September 30 (in shares) [4] 4,202,000 5,517,000 4,202,000 5,517,000
Intrinsic Value of Stock Options/SARs Exercised [1]     $ 103,700 $ 66,600
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years)     4 years 9 months 18 days 4 years 3 months 18 days
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest [1] $ 261,900 $ 145,900 $ 261,900 $ 145,900
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)     4 years 8 months 12 days 4 years 3 months 18 days
Aggregate Intrinsic Value for Exercisable Units [1] 175,500 123,200 $ 175,500 $ 123,200
Weighted average remaining contractual life for exercisable options/SARs (in years)     3 years 4 months 24 days [1] 2 years 9 months 18 days
Weighted Average Grant Price Stock Option and SARs [Rollforward]        
Intrinsic Value of Stock Options/SARs Outstanding [1] $ 269,100 $ 147,800 $ 269,100 $ 147,800
Outstanding at January 1 (price per share)     $ 83.89 $ 75.53
Granted (price per share)     126.65 96.24
Exercised (1) (price per share) [1]     69.62 55.63
Forfeited (price per share)     91.89 90.22
Outstanding at September 30 (2) (price per share) [2] $ 96.55 $ 83.02 96.55 83.02
Vested or Expected to Vest (3) (price per share) [3] 96.08 82.69 96.08 82.69
Exercisable at September 30 (4) (price per share) [4] $ 85.80 $ 75.59 85.80 75.59
ESPP [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 25.52 $ 22.10
Expected Volatility (in hundredths)     24.36% 26.96%
Risk-Free Interest Rate (in hundredths)     1.86% 0.89%
Dividend Yield (in hundredths)     0.64% 0.71%
Expected Life (in years)     6 months 6 months
Restricted Stock And Restricted Stock Units [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Unrecognized compensation expense [1] $ 194,500   $ 194,500  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 2 months 12 days  
Intrinsic value released during the year [1]     $ 80,200 $ 81,600
Aggregate intrinsic value of stock and units outstanding [1] 489,700 $ 386,600 489,700 386,600
Restricted Stock/Restricted Stock Units [Roll Forward]        
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost [1] $ 17,500 $ 15,800 $ 58,800 $ 50,000
Outstanding at January 1 (in shares)     3,905,000 3,962,000
Granted (in shares)     792,000 1,061,000
Released (1) (in shares) [5]     (708,000) (837,000)
Forfeited (in shares)     (150,000) (190,000)
Outstanding at September 30 (2) (in shares) [6] 3,839,000 3,996,000 3,839,000 3,996,000
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (price per share)     $ 88.57 $ 79.63
Granted (price per share)     117.67 97.26
Released (1) (price per share) [5]     77.46 59.67
Forfeited (price per share)     91.36 84.66
Outstanding at September 30 (2) (price per share) [6] $ 96.52 $ 88.25 $ 96.52 $ 88.25
Performance Units and Performance Stock [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans [1] $ 9,800 $ 6,800 $ 12,100 $ 8,600
Unrecognized compensation expense 11,000   $ 11,000  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     1 year 8 months 12 days  
Intrinsic value released during the year     $ 17,700 23,600
Aggregate intrinsic value of stock and units outstanding $ 68,000 $ 48,600 $ 68,000 $ 48,600
Minimum Performance Units and Stock Allowed to be Outstanding       143,610
Maximum Performance Units and Stock Allowed to be Outstanding       921,940
Restricted Stock/Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (in shares)     502 545
Granted (in shares)     107 78
Granted for Performance Multiple (1)     72 119
Released (1) (in shares)     148 240
Forfeited (in shares)     0 0
Outstanding at September 30 (2) (in shares) 533 502 533 502
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (price per share)     $ 90.96 $ 80.92
Granted (price per share)     127.00 96.29
Granted for Performance Multiple (1) (in dollars per share)     101.87 84.43
Released (1) (price per share)     84.43 66.69
Forfeited (price per share)     0.00 0.00
Outstanding at September 30 (2) (price per share) $ 101.50 $ 90.96 $ 101.50 $ 90.96
Performance Units and Performance Stock Disclosures [Abstract]        
Performance Period for Performance Units and Shares     3 years  
Minimum Performance Multiple at the Completion of the Performance Period     0.00%  
Maximum Performance Multiple at the Completion of the Performance Period     200.00%  
Lease and Well        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 12,900 $ 9,500 $ 37,100 $ 30,000
Gathering and Processing Costs        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 100 100 300 500
Exploration Costs        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 5,800 4,700 18,400 16,100
General and Administrative        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 30,200 $ 29,200 $ 60,500 $ 54,900
[1] The total intrinsic value of stock options/SARs exercised for the nine months ended September 30, 2018 and 2017 was $103.7 million and $66.6 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at September 30, 2018 and 2017 was $269.1 million and $147.8 million, respectively. At September 30, 2018 and 2017, the weighted average remaining contractual life was 4.8 years and 4.3 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2018 and 2017 was $261.9 million and $145.9 million, respectively. At September 30, 2018 and 2017, the weighted average remaining contractual life was 4.7 years and 4.3 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at September 30, 2018 and 2017 was $175.5 million and $123.2 million, respectively. At September 30, 2018 and 2017, the weighted average remaining contractual life was 3.4 years and 2.8 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released for the nine months ended September 30, 2018 and 2017 was $80.2 million and $81.6 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2018 and 2017 was $489.7 million and $386.6 million, respectively.